Cell and gene therapies are amongst the most complex and advanced medical treatments under development and are revolutionizing approaches to treating a wide range of diseases that currently have very poor or no effective intervention. Cells, each of which contains full genetic information, are the building blocks for complex life. Genes carry information in the form of DNA which, not only determines physical characteristics but also governs the day-to-day functioning of the body’s biological processes and ultimately maintains health. A genetic disorder or disease occurs when a segment of DNA is damaged, missing, duplicated, or substituted, causing the body to function unexpectedly. This can be seen in conditions like Cancer where a dividing cell mutates and develops a genetic abnormality, that causes it to begin to reproduce rapidly developing into a tumor. Other clinical conditions associated with genetic disorders are often described as rare and complex diseases. This disease caused o genetic level so they treated it with gene therapy and cell therapies.
Cell therapy uses cultivated cells that have been genetically modified to address a specific genetic condition. Cells cultivated under carefully controlled conditions are introduced to the patient and contain vital genetic information to introduce the required therapeutic effect. Cells can be acquired from an individual patient whose cells are processed and re-administered into the patient, known as autologous cell therapy. In some instances, cells may have been adapted from donor cells. this is known as allogeneic cell therapy. Gene therapy is a new-age treatment, it works by changing a patient’s DNA on a cellular level either with treatments inside the body or outside the body. Many of these treatments use therapeutic viruses which are engineered to introduce changes in a patient’s cells. These new medicines treat genetic diseases at the source by affecting changes in their tissue, cells, or DNA with the potential to be effective only once.
Global Cell & Gene Therapy Market – Competitive Landscape
On November 1, 2023, AstraZeneca signed a joint research collaboration agreement with Cellectis to develop up to ten cell and gene therapy candidates. As part of the agreement, Cellectis will receive a USD 25 million upfront payment and an initial equity investment of USD 80 million. On July 5, 2023, LabCorp partnered with Forge Biologics for gene therapies. On May 10, 2023, Cathay Health backed Ascend Gene and Cell Therapies launches with over USD 130 million in funding. On January 9, 2023, Sanguine Bioscience partnered with Broadoak Capital partners to accelerate the launch of new products and services in support of the cell & gene therapy market.
Some of the Key Players in the Global Cell and gene Therapy Market Include –
Global Cell & Gene Therapy Market – Growth Drivers
The rising prevalence of genetic disorders and rare diseases globally is a significant driver for the growth of the cell and gene therapy market. These therapies offer targeted and personalized treatment options for patients with specific genetic conditions. According to the World Health Organization genetic disorders and congenital abnormalities occur in about 2%-5% of all live births, account for up to 30% of pediatric hospital admissions, and cause about 50% of childhood deaths in industrialized countries. Ongoing advancements in genomic research, including the identification of genetic targets and understanding of disease mechanisms, provide a strong foundation for the development of novel cell and gene therapies, driving innovation in the market. The demographic shift towards an aging population contributes to the increased prevalence of age-related diseases. Cell and gene therapies present opportunities for addressing degenerative conditions associated with aging, driving market growth. Continuous progress in gene editing technologies, such as CRISPR-Cas9, TALENs, and zinc-finger nucleases, accelerate the development of precise and efficient cell and gene therapies and efficient cell and gene therapies fostering market expansion. Supportive regulatory frameworks and expedited approval processes from agencies like the U.S. FDA and EMA facilitate the development and commercialization of cell and gene therapies. This regulatory support acts as a catalyst for market growth. Growing investments from pharmaceutical companies, biotech firms, and government organizations in cell and gene therapy research and development contribute to the expansion of the market by fostering innovation and accelerating product pipelines. The broader shift in healthcare towards personalized medicine aligns with the principles of cell and gene therapy, offering tailored treatments based on individual genetic profiles. This trend propels the market forward as personalized approaches gain prominence.
Global Cell & Gene Therapy Market– Restraints
One of the primary restraints facing the global cell and gene therapy market is the high cost associated with the development, manufacturing, and administration of these therapies. The price is USD 3.5 million per treatment, making the therapy, called Hemgenix the most expensive drug in the world. Affordability remains a significant barrier to widespread adoption. The intricate and resource-intensive manufacturing processes involved in producing cell and gene therapies contribute to challenges in scalability, production efficiency, and cost-effectiveness, hindering large-scale accessibility. Inconsistent or limited reimbursement policies for cell and gene therapies pose a significant obstacle. The lack of a comprehensive reimbursement framework may deter healthcare providers and limit patient access to these innovative treatments. Limited long-term safety data for some cell and gene therapies raises concern among regulatory bodies, healthcare professionals, and patients. Addressing and establishing the long-term safety profile of these therapies is crucial for gaining wider acceptance. Despite regulatory support, navigating complex regulatory landscapes and obtaining approvals for novel cell and gene therapies can be time-consuming and challenging. Stringent regulatory requirements may slow down the market’s growth. Ethical considerations related to gene editing and genetic modifications, along with potential social and cultural concerns may lead to public resistance and impact the acceptance of cell and gene therapies. Insufficient long-term clinical data on the efficacy and safety of certain cell and gene therapies create uncertainty among healthcare professionals and regulators, influencing the cautious adoption of these treatments.
Global Cell & Gene Therapy Market – Opportunities
The global cell and gene therapy market presents opportunities for expansion into diverse therapeutic areas, into diverse therapeutic areas, including oncology, rare genetic disease, cardiovascular disorders, and autoimmune conditions, providing a broad scope for addressing unmet medical needs. The shift towards personalized medicine opens up avenues for cell and gene therapies, allowing tailored treatments based on individual patient profiles. This trend aligns with the growing emphasis on precision medicine and targeted therapeutic approaches. Increasing patient advocacy and awareness initiatives contribute to a better understanding of cell and gene therapies, potentially leading to higher patient acceptance and demand for innovative treatment options.
Global Cell & Gene Therapy Market – Geographical Insight
The market for global cell and gene therapy is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market for cell and gene therapy due to robust research infrastructure, supportive regulatory frameworks, and a high level of investment in biotechnology. Europe is a significant player in the cell and gene therapy sector, with countries like the United Kingdom, Germany, and Switzerland actively contributing to research and development efforts. Regulatory approvals from the European Medicines Agency further strengthen the market in this region. The Asia-Pacific region is witnessing substantial growth in the cell and gene therapy market. Countries like China and Japan are making notable strides, driven by advancements in healthcare infrastructure, increasing R&D activities, and a growing emphasis on personalized medicine.
Global Cell & Gene Therapy Market – Key Development
Research Methodology: Aspects
Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.
The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.
Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.
Key phases involved in in our research process are mentioned below:
Understanding Clients’ Objectives:
Extensive Discussions and Consultations:
Industry and Market Segment Analysis:
Target Audience Understanding:
Identifying Challenges and Opportunities:
Grasping Specific Goals:
Data Collection:
Primary Research Process:
Secondary Research Process:
Data Analysis:
The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.
Transformation of Raw Data:
Utilization of Analytical Methods:
Statistical Analysis:
Qualitative Analysis Techniques:
Integrity and Validity Maintenance:
Data Validation:
The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.
Importance of Data Validation:
Scrutiny of Collected Data:
Validation Techniques:
Internal Quality Assurance Protocols:
We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Cognizance market research is continuously guiding customers around the globe towards strategies for transformational growth. Today, businesses have to innovate more than ever before, not just to survive, but to succeed in the future
© 2023 All rights Reserved. Cognizance Market Research
